Total Payments
$140,132
2023 Payments
$15,719
Companies
12
Transactions
47
Medicare Patients
2,759
Medicare Billing
$178,812
Payment Breakdown by Category
Other$100,000 (71.4%)
Research$18,132 (12.9%)
Consulting$13,200 (9.4%)
Travel$7,512 (5.4%)
Food & Beverage$1,288 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Entertainment | $70,000 | 2 | 50.0% |
| Honoraria | $30,000 | 9 | 21.4% |
| Unspecified | $18,132 | 4 | 12.9% |
| Consulting Fee | $13,200 | 1 | 9.4% |
| Travel and Lodging | $7,512 | 10 | 5.4% |
| Food and Beverage | $1,288 | 21 | 0.9% |
Payments by Type
General
$122,000
43 transactions
Research
$18,132
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Resmed Corp | $70,000 | 2 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $38,096 | 30 | $0 (2023) |
| Akcea Therapeutics, Inc. | $16,668 | 2 | $0 (2020) |
| JenaValve Technology, Inc. | $13,292 | 2 | $0 (2023) |
| Vericel Corporation | $1,500 | 3 | $0 (2017) |
| ABIOMED | $143.16 | 1 | $0 (2017) |
| Novo Nordisk Inc | $127.75 | 1 | $0 (2022) |
| Amgen Inc. | $109.98 | 1 | $0 (2017) |
| Terumo Medical Corporation | $109.16 | 1 | $0 (2018) |
| PFIZER INC. | $33.18 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15,719 | 3 | JenaValve Technology, Inc. ($13,200) |
| 2022 | $233.99 | 3 | Novo Nordisk Inc ($127.75) |
| 2021 | $5,000 | 2 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($5,000) |
| 2020 | $16,668 | 2 | Akcea Therapeutics, Inc. ($16,668) |
| 2019 | $53.62 | 2 | AstraZeneca Pharmaceuticals LP ($31.29) |
| 2018 | $6,600 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($6,491) |
| 2017 | $95,858 | 32 | Resmed Corp ($70,000) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/30/2023 | JenaValve Technology, Inc. | JenaValve Pericardial TAVR System (Device) | Consulting Fee | Cash or cash equivalent | $13,200.00 | General |
| Category: Cardiology | ||||||
| 02/23/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2022 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $127.75 | General |
| 04/01/2022 | JenaValve Technology, Inc. | JenaValve Pericardial TAVR System (Device) | Food and Beverage | Cash or cash equivalent | $91.66 | General |
| Category: Cardiology | ||||||
| 11/23/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/19/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/19/2020 | Akcea Therapeutics, Inc. | — | — | Cash or cash equivalent | $16,632.00 | Research |
| Study: The APPROACH Open-Label Extension, An Open-Label Extension Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS) | ||||||
| 02/08/2020 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $36.04 | General |
| Category: NEUROLOGY | ||||||
| 03/18/2019 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $22.33 | General |
| 02/01/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.29 | General |
| 08/11/2018 | Terumo Medical Corporation | MetaCross (Device), AngioSeal | Food and Beverage | Cash or cash equivalent | $109.16 | General |
| Category: Lesion Therapy | ||||||
| 07/18/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/18/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Travel and Lodging | Cash or cash equivalent | $1,490.80 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/06/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $97.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/26/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Travel and Lodging | Cash or cash equivalent | $1,716.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/19/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/13/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Travel and Lodging | Cash or cash equivalent | $275.75 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/12/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $93.89 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/11/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $54.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/21/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/21/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Travel and Lodging | Cash or cash equivalent | $850.74 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| The APPROACH Open-Label Extension, An Open-Label Extension Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS) | Akcea Therapeutics, Inc. | $16,632 | 1 |
| An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) (ixCELL DCM) | Vericel Corporation | $1,500 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 867 | 971 | $303,129 | $57,053 |
| 2022 | 9 | 592 | 722 | $215,414 | $41,306 |
| 2021 | 11 | 717 | 818 | $281,151 | $45,985 |
| 2020 | 11 | 583 | 679 | $249,504 | $34,468 |
Total Patients
2,759
Total Services
3,190
Medicare Billing
$178,812
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 305 | 310 | $89,900 | $17,025 | 18.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 75 | 108 | $51,921 | $12,004 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 103 | 154 | $53,878 | $10,746 | 19.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 46 | 46 | $47,784 | $7,393 | 15.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 23 | 23 | $9,223 | $2,011 | 21.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $9,532 | $1,940 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $7,756 | $1,519 | 19.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 19 | 19 | $5,932 | $1,156 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 18 | $4,072 | $896.02 | 22.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 23 | 24 | $3,144 | $491.28 | 15.6% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 55 | 55 | $4,950 | $412.78 | 8.3% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2023 | 12 | 12 | $1,704 | $376.20 | 22.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 49 | 60 | $1,980 | $374.66 | 18.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 35 | 36 | $1,296 | $209.88 | 16.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 21 | 21 | $4,158 | $209.79 | 5.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 22 | 22 | $3,134 | $197.40 | 6.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 34 | 35 | $2,765 | $89.25 | 3.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 262 | 275 | $79,750 | $15,726 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 113 | 210 | $61,950 | $15,647 | 25.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 31 | 31 | $26,426 | $3,863 | 14.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 19 | $8,246 | $2,324 | 28.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2022 | 25 | 26 | $23,920 | $1,764 | 7.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 26 | $5,304 | $823.93 | 15.5% |
| 76376 | 3d radiographic procedure | Facility | 2022 | 53 | 55 | $4,950 | $435.36 | 8.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 12 | 13 | $1,703 | $274.00 | 16.1% |
About Dr. Anthony Demaria, M.D
Dr. Anthony Demaria, M.D is a Cardiovascular Disease healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124043948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Demaria, M.D has received a total of $140,132 in payments from pharmaceutical and medical device companies, with $15,719 received in 2023. These payments were reported across 47 transactions from 12 companies. The most common payment nature is "Entertainment" ($70,000).
As a Medicare-enrolled provider, Demaria has provided services to 2,759 Medicare beneficiaries, totaling 3,190 services with total Medicare billing of $178,812. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Diego, CA
- Active Since 07/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1124043948
Products in Payments
- LifeVest (Device) $38,096
- JenaValve Pericardial TAVR System (Device) $13,292
- ixmyelocel-T (Biological) $1,500
- Impella (Device) $143.16
- Repatha (Biological) $109.98
- MetaCross (Device) $109.16
- TEGSEDI (Drug) $36.04
- ELIQUIS (Drug) $33.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Diego
Jonathan Hsu, Md, MD
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Dr. Raghava Gollapudi, M.d, M.D
Cardiovascular Disease — Payments: $572,162
Cardiovascular Disease $572,162
Dr. Hirsch Mehta, Md, MD
Cardiovascular Disease — Payments: $527,825
Cardiovascular Disease $527,825
Dr. Barry Greenberg, M.d, M.D
Cardiovascular Disease — Payments: $463,770
Cardiovascular Disease $463,770
Dr. Mitul Patel, M.d, M.D
Cardiovascular Disease — Payments: $459,569
Cardiovascular Disease $459,569
Dr. Ulrika Birgersdotter-Green, Md, MD
Cardiovascular Disease — Payments: $430,713
Cardiovascular Disease $430,713